Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial

Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial

Summary

A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test...

Description

A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage